Sort
35,931 grants matching “parkinsons”
Pro-inflammatory cytokine lowering anti-inflammatory drugs
$1,864,880Nigel H. Greig · National Institute On Aging · ZIA · FY2021 · AG
Biospecimen Exchange for Neurological Disorders (BioSEND)
$1,864,635Tatiana M. Foroud · Indiana University Indianapolis · U24 · FY2022 · NS
Molecular Pathogenesis of Age-Dependent CNS Degeneration
$1,863,679University Of California San Francisco · P01 · FY2005 · AG
Mitochondrial Dysfunction in Aging and Disease
$1,863,135Julie Kay Andersen · Buck Institute For Research On Aging · P01 · FY2011 · AG
ALDH1A1-Negative Nigrostriatal Dopaminergic Neuron Subtypes in Parkinsons Disease
$1,862,991Huaibin Cai · National Institute On Aging · ZIA · FY2025 · AG
Parkinson's Disease Gene Therapy Study Group
$1,860,926University Of Rochester · U54 · FY2003 · NS
Function and Regulation of ALDH1A1-positive Nigrostriatal Dopaminergic Neurons in Motor Control and Parkinson's disease
$1,860,870Huaibin Cai · National Institute On Aging · ZIA · FY2021 · AG
Post-translational modification and protein quantification of plasma and CSF
$1,860,708Jennifer E Van Eyk · Cedars-Sinai Medical Center · U01 · FY2019 · NS
AGE RELATED NEURODEGENERATIVE DISEASES IN MICRONESIA
$1,859,796University Of California San Diego · P01 · FY2001 · AG
HABS-HD - Core B - Neuroimaging & Informatics Core
$1,858,021Sid E O'Bryant · University Of North Texas Hlth Sci Ctr · U19 · FY2023 · AG
HABS-HD - Core B - Neuroimaging & Informatics Core
$1,857,998Sid E O'Bryant · University Of North Texas Hlth Sci Ctr · U19 · FY2024 · AG
Biomarkers of Catecholaminergic Neurodegeneration
$1,854,141David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
Linking Tau Structure to Its Functions and Mechanisms in Alzheimerâs Disease
$1,849,316George S Bloom · University Of Virginia · RF1 · FY2016 · AG
IND enabling CMC/safety/toxicology studies, submission of IND and pilot Phase 1 clinical trial with PV-1950R vaccine for Lewy Body Dementia (LBD)
$1,849,047Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2025 · AG
Parkinson's Disease and Dementia
$1,845,465John Q. Trojanowski · University Of Pennsylvania · P50 · FY2011 · NS
Human Blood-Brain Barrier Model for CNS Drug Translation
$1,844,274Eric V Shusta · University Of Wisconsin-Madison · RC4 · FY2010 · AA
Development of a Clinical Hemoglobin Modulator
$1,843,809Susan P Perrine · Phoenicia Biosciences, Inc. · R33 · FY2021 · HL
NIEHS Cryo-EM Core Facility
$1,842,598Mario Borgnia · National Institute Of Environmental Health Sciences · ZIC · FY2022 · ES
Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease
$1,840,995William T Dauer · University Of Michigan At Ann Arbor · P50 · FY2016 · NS
Molecular Pathogenesis of Age-Dependent CNS Degeneration
$1,839,930Stanley B Prusiner · University Of California, San Francisco · P01 · FY2006 · AG
Environmentally Induced Alterations In Neuron And Glia Development and Aging
$1,836,340Gaylia Jean Harry · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES
BIOMEDICAL INFORMATICS RESEARCH NETWORK: NEUROLOGICAL DISORDERS
$1,836,100Mark H Ellisman · University Of California, San Diego · U24 · FY2008 · RR
BIOMEDICAL IMAGING RESEARCH NETWORK: NEUROLOGICAL DISORDERS
$1,836,099Mark H Ellisman · University Of California, San Diego · U24 · FY2008 · RR
Ultra-high sensitivity, high spatial resolution single photon emission tomography using mechanical flux manipulation
$1,835,001Larry Pierce · Quant, Inc. · R44 · FY2025 · MH
CONNECT-TBI
$1,834,861Douglas Hamilton Smith · University Of Pennsylvania · U54 · FY2020 · NS